QT Imaging Achieves Sub-1% Variability in Key Breast Imaging Biomarkers
Event summary
- QT Imaging reported <1% variability in Speed of Sound (SoS) measurements across its Breast Acoustic CT Scanner platform, with volumetric biomarkers showing 5-12% variability.
- Study conducted at two clinical sites with five patients each, scanned five times per site to assess within-scanner and cross-scanner consistency.
- Results contrast sharply with published breast MRI biomarker variability of 11-22%, positioning QT Imaging's technology as more reproducible.
- CEO Raluca Dinu emphasized the operator-independent nature of the platform as a key differentiator.
The big picture
As quantitative imaging biomarkers gain traction in breast health management, reproducibility emerges as a critical differentiator. QT Imaging's results position it favorably against MRI-based diagnostics, where variability ranges from 11-22%. The findings could accelerate adoption of radiation-free imaging solutions in clinical decision-making, particularly for longitudinal monitoring and treatment response assessment.
What we're watching
- Clinical Adoption Pace
- How quickly QT Imaging can translate these reproducibility metrics into broader clinical adoption and regulatory approvals.
- Competitive Differentiation
- Whether the sub-1% variability in SoS measurements will provide a sustainable advantage over MRI-based diagnostics.
- Longitudinal Monitoring Potential
- The pace at which QT Imaging can establish its biomarkers as standards for longitudinal disease monitoring and treatment response assessment.